Druhé pokračování o významu vitaminu D pro zdraví člověka (první bylo publikováno v Živě 4/2015) se zabývá jeho úlohou, kterou hraje v imunitě. Donedávna se nepředpokládalo, že by vitamin D mohl podmiňovat také imunitní procesy. Během posledních let se však nashromáždil dostatečný počet experimentálních i klinických studií, které dokládají, že při jeho nedostatečném příjmu dochází k poklesu zejména antiinfekční imunity, a souběžně s tím stoupá také riziko vzniku nesdělných onemocnění. Účelem tohoto sdělení není vyčerpávající informace o mechanismech jeho působen na imunitní systém, ale upozornění pro specialisty i laiky na tuto důležitou, ale prozatím opomíjenou problematiku., This is a further continuation of an 8/2015 article about the importance of vitamin D to the health of human beings (the first was published in Živa 4/2015). The article deals with the role that the vitamin plays in immunity. Until recently, it was not assumed that vitamin D could also be conditional upon immune processes and that it determines the correct function of both natural and adaptive immunity. In recent years, however, a sufficient number of experimental and clinical studies have accumulated, providing evidence that insufficient intake of vitamin D could not only induce decreased immunity to infection but also contribute substantially to an increased risk of non-communicable diseases. The purpose of this communication is not exhaustive information on the mechanisms of vitamin D effects on the immune system, but as an alert to specialists and laymen on hitherto neglected issues., and Petr Šíma, Bohumil Turek.
The relationship between vitamin D receptor (VDR) intragenic polymorphisms FokI, BsmI, ApaI and TaqI and bone mineral density (BMD) or biochemical markers of bone remodeling were investigated in 114 Czech postmenopausal women, on the average 62.5±8.9 years of age. Restriction fragment length polymorphisms in the VDR gene were assessed by PCR amplification and digestion with restriction enzymes FokI, BsmI, ApaI, and TaqI recognizing polymorphic sites in the VDR locus. Bone mineral density was measured at the lumbar spine and at the hip by dual-energy X-ray absorptiometry (DEXA, g/cm2). After adjusting for age and the body mass index (BMI), subjects with the ff genotype had 9.4 % lower BMD at the hip than those with the Ff genotype (p=0.0459, Tukey´s test). FF individuals had an intermediate BMD at the hip. A similar pattern of lower lumbar spine BMD was also found in ff individuals, but it did not reach statistical significance. There was no relationship between BsmI, ApaI and TaqI VDR polymorphisms and BMD at any skeletal site. Subjects with Aa (ApaI) genotypes had higher levels of propeptide of type I collagen (PICP) than homozygous AA (p=0.0459, Tukey´s test). In FokI, BsmI and TaqI restriction sites the biochemical markers of bone remodeling did not differ by genotype. In addition, no significant difference was observed in VDR genotypic distribution between osteoporotic women and non-osteoporotic controls in the study group. To conclude, the FokI genotype of the vitamin D receptor gene is related to bone mass at the hip in Czech postmenopausal women, whereas the importance of remaining VDR genotypes was not evident., K. Zajíčková, I. Žofková, R. Bahbouh, A. Křepelová., and Obsahuje bibliografii